Conference Proceedings

Clinical Activity of Lorlatinib in Patients with ROS1 Advanced Non-Small Cell Lung Cancer: Phase 2 Study Cohort EXP-6

S Ou, A Shaw, G Riely, R Chiari, J Bauman, J Clancy, H Thurm, G Peltz, A Abbattista, B Solomon

JOURNAL OF THORACIC ONCOLOGY | ELSEVIER SCIENCE INC | Published : 2018

DOI: 10.1016/j.jtho.2018.08.241

University of Melbourne Researchers

Citation metrics

19Web of Science
21Dimensions

Keywords

Lung
32 Biomedical and Clinical Sciences
Lorlatinib
Lung Cancer
Life Sciences & Biomedicine
Respiratory System
Nsclc
Clinical Research
Science & Technology
Cancer
6.9 Resources and Infrastructure (treatment Evaluation)
Women'S Health
Oncology
3211 Oncology and Carcinogenesis
Ros1
Clinical Trials and Supportive Activities